Comparative observation on changes in serum lipid profile level in patients undergoing snehana (internal oleation) with pure ghee in one group and Mahatiktaka ghrita (medicated ghee)in other group

Comparative observation on changes in serum lipid profile in patients undergoing snehana with pure ghee in one group and Mahatiktaka ghrita in other group

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009589

Enrollment

Registered

2017-09-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 2: null- Patients suffering from skin disorder

Interventions

Intervention1: Pure ghee: a. Pachana (Digestive) with Panchakola churna 3gm twice a day for 3 daysa. b. Pure ghee of cow once daily with lukewarm water at 6.00 am for 3 to 7 days depending upon manife

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with either sex aged between 18- 40 years. 2. Patients suffering from skin disorder (like eczema, psoriasis, acne vulgaris) in which Snehana and virechana is indicated. 3. Willing and able to participate in the study

Exclusion criteria

Exclusion criteria: 1. Age 40yrs 2. Patients suffering from Peptic ulcer, Hypertension, Diabetes Mellitus 3. Patients suffering from hyperlipidemia (lipid profile level more than normal range) 4. Patients with concurrent hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Pulmonary Dysfunction (Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), or any other condition that may jeopardize the study. 5. Known case of hypothyroidism. 6. Patients with evidence of malignancy. 7. Patients on prolonged ( > 6 weeks) medication with corticosteroids, diuretics, antidislipidaemic, etc. or any other drugs that may have an influence on the outcome of the study. 8. Pregnant / lactating woman. 9. Patients who are currently participating in any other clinical trial 10. Any other condition which the Principal Investigator thinks may jeopardize the study.

Design outcomes

Primary

Measure	Time frame
Changes in fasting serum lipid profileTimepoint: from baseline to next day of virechana	—

Secondary

Measure	Time frame
comparison of Changes in Sr. Cholesterol and Sr. Triglycerides in two groupsTimepoint: from baseline to next day of virechana	—

Countries

India

Contacts

Public ContactDr Deepa Makhija

Central Ayurveda Research Institute for Cardio-vascular Diseases

drdeepamakhija@yahoo.co.in9911331074

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026